Trial
NCT01083641
Estrogen for Triple Negative Breast Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University of Wisconsin, Madison
Collaborators
National Cancer Institute (NCI)
Condition
Female Breast Cancer
Intervention
Estradiol
Why stopped
did not meet efficacy goals after interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-09